Skip to main content

News categories: Honors & Funding

5 ImmunoSensation Highly Cited Researchers

ImmunoSensation is represented with 5 "Highly Cited Researchers" in Immunology and Cross-Field in this year's international ranking from Clarivate.

According to the creators of the ranking, the individuals on this list of "Highly Cited Researchers" are among the world's most influential one percent of their field.

The benchmark is the frequency with which their scientific publications were cited by other researchers in the past decade (period from 2012t o 2022). The ranking is published annually by the "Web of Science Group" and includes around 7,100 scientists from 67 different countries.

The most cited researchers at ImmunoSensation are:

Thomas Bieber, Cross-Field
Eicke Latz, Immunology
Andreas Schlitzer, Cross-Field
Jonathan L. Schmid-Burgk, Cross-Field
Joachim L. Schultze, Immunology

The University of Bonn is represented with a total of 11 researchers.

Further information: https://recognition.webofscience.com/awards/highly-cited/2023/

Press release University of Bonn: https://www.uni-bonn.de/en/news/213-2023?set_language=en

Symbolic photo - Large amounts of data were analyzed for the "Highly Cited Researchers".
Symbolic photo - Large amounts of data were analyzed for the "Highly Cited Researchers".
© Photo: Volker Lannert/Uni Bonn

Related news

Christina Weisheit

News categories: Honors & Funding

Finding novel therapies for aortic valve diseases

The DFG funds the project of Christina Weisheit and collaborators with 600,000 euros.
View entry
GTH Preis

News categories: Honors & Funding

The Becker-Gotot group is awarded at the GTH 2024 in Vienna

Janine Becker-Gotot and Amina Abdelmageed receive awards for their intriguing studies at the GTH 2024 in Vienna.
View entry
Radosław P. Nowak is Professor of Immune Engineering and Drug Discovery at the University Hospital Bonn

News categories: Honors & Funding

Expert in the targeted degradation of proteins

Radosław P. Nowak is Professor of Immune Engineering and Drug Discovery at the University Hospital Bonn
View entry

Back to the news overview